Archive · 5 Dec 2025
Corona Remedies IPO: Key Details
Corona Remedies, a pharmaceutical company, is launching its IPO in India.
The IPO is worth Rs 655.37 crore and is an Offer for Sale, meaning the company won't receive any funds; the selling shareholders will.
The price of each share is between Rs 1,008 and Rs 1,062.
The IPO will be open from December 8 to December 10, with the listing expected on December 15.
The shares are currently trading at a premium in the grey market, but this isn't official.
Retail investors can buy a minimum of 14 shares and a maximum of 182 shares.
The IPO is managed by JM Financial, IIFL Capital Services, and Kotak Mahindra Capital.
Corona Remedies is launching an IPO worth Rs 655.37 crore, entirely as an Offer for Sale (OFS).
The price band is set between Rs 1,008 and Rs 1,062 per share, with a face value of Rs 10.
The IPO will open on December 8 and close on December 10, with a tentative listing date of December 15.
Shares are trading at a grey market premium of around 35% over the upper price band.
Retail investors can apply for a minimum of 14 shares and a maximum of 182 shares.
- Who
- Corona Remedies, a pharmaceutical company
- What
- IPO launch
- When
- December 8-10, 2023
- Where
- India
- Why
- Offer for Sale (OFS) by existing shareholders
- Issue Size
- Rs 655.37 crore
- Price Band
- Rs 1,008-1,062 per share
- Face Value
- Rs 10 per share
- IPO Type
- Offer for Sale (OFS)
- GMP
- Rs 1,427 (35% premium)
- IPO Open Date
- December 8
- IPO Close Date
- December 10
- Listing Date
- December 15 (tentative)